New Delivery Option for Ketamine

Video

How can new formulations of ketamine impact patient care?

Jeffrey Becker, MD, discusses new formulations of ketamine for subcutaneous delivery and how ketamine works.

Dr Becker is cofounder and Chief Scientific Officer at Bexson Biomedical, Inc.

Related Videos
“What we’re striving to do is conquer the unmet needs that are still here with treating ADHD, especially from a medication standpoint.”
Work takes up one-third of a patient’s life—it is important that we pay attention to it.
A new treatment in development is poised to be a game-changer for patients with postpartum depression.
An expert discusses the latest on EndeavorRx and more digital therapeutics for this patient population.
Related Content

Girls and Their Monsters, Part 3

September 18th 2023

EMPOWERing the Next Generation

September 13th 2023

Girls and Their Monsters, Part 2

September 7th 2023

The Joy of Sailing

September 4th 2023

Girls and Their Monsters, Part 1

August 28th 2023

A Journey of Juggling

August 25th 2023

Girls and Their Monsters, Part 3

September 18th 2023

EMPOWERing the Next Generation

September 13th 2023

Girls and Their Monsters, Part 2

September 7th 2023

The Joy of Sailing

September 4th 2023

Girls and Their Monsters, Part 1

August 28th 2023

A Journey of Juggling

August 25th 2023

Girls and Their Monsters, Part 3

September 18th 2023

EMPOWERing the Next Generation

September 13th 2023

Girls and Their Monsters, Part 2

September 7th 2023

The Joy of Sailing

September 4th 2023

Girls and Their Monsters, Part 1

August 28th 2023

A Journey of Juggling

August 25th 2023
© 2023 MJH Life Sciences

All rights reserved.